Novel iontophoretic drug delivery systems
First Claim
1. An electrotransport device for transporting molecules of a beneficial agent from a reservoir across a semipermeable membrane and into an ionic fluid, said electrotransport device comprising:
- a first compartment including a first electroactive material configured as a first electrode, said first compartment adapted for containing a beneficial agent therein;
a first semipermeable membrane disposed adjacently under at least a portion of said first compartment and in fluid communication with the beneficial agent contained therein, said semipermeable membrane configured to be in fluid communication with an ionic fluid in an environment in which said electrotransport device is placed;
a second electrode comprising a second electroactive material in communication with the ionic fluid; and
a conductor, insulated from the ionic fluid, said conductor extending from said first electrode to said second electrode and providing an electrical interconnection therebetween, said first and second electroactive materials when electrically connected with said conductor and said ionic fluid forming a battery.
2 Assignments
0 Petitions
Accused Products
Abstract
An electrotransport device is provided for the site specific delivery of drugs or other beneficial agents across or under a skin or tissue surface. In one embodiment, the electrotransport device is configured in whole, or in part, to be implanted under a subject'"'"'s stratum corneum, and uses an electrical current to facilitate drug or other beneficial agent delivery through a semipermeable membrane and into the tissue of the subject. In another embodiment, a device for intraocular delivery of drug or beneficial agent is disclosed which device is placed on the conjunctiva of a subject, wherein lacrimal fluid completes a circuit for delivering the drug or beneficial agent. Methods of using the devices of the present invention are also provided.
-
Citations
38 Claims
-
1. An electrotransport device for transporting molecules of a beneficial agent from a reservoir across a semipermeable membrane and into an ionic fluid, said electrotransport device comprising:
-
a first compartment including a first electroactive material configured as a first electrode, said first compartment adapted for containing a beneficial agent therein;
a first semipermeable membrane disposed adjacently under at least a portion of said first compartment and in fluid communication with the beneficial agent contained therein, said semipermeable membrane configured to be in fluid communication with an ionic fluid in an environment in which said electrotransport device is placed;
a second electrode comprising a second electroactive material in communication with the ionic fluid; and
a conductor, insulated from the ionic fluid, said conductor extending from said first electrode to said second electrode and providing an electrical interconnection therebetween, said first and second electroactive materials when electrically connected with said conductor and said ionic fluid forming a battery. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. An electrotransport device for delivering molecules of a beneficial agent to tissue of a subject, said electrotransport device comprising:
-
a plurality of mutually spaced apart electrodes, each of said plurality of mutually spaced apart electrodes adapted to be placed over a subject'"'"'s tissue surface;
at least one conductor extending between two of said plurality of mutually spaced apart electrodes;
at least one reservoir disposed under an electrically conducting area of a first electrode of said plurality of mutually spaced apart electrodes, said at least one reservoir adapted to accommodate the molecules of beneficial agent; and
a semipermeable membrane disposed adjacently under said at least one reservoir, said semipermeable membrane adapted to be implanted under at least a portion of the tissue of a subject. - View Dependent Claims (19, 20, 21, 22, 23, 24, 25, 26, 28, 29)
-
-
27. A method of electrically facilitating the transport of a beneficial agent to a body tissue of a subject, said method comprising:
-
providing a plurality of electrodes configured to conduct electrical current in relation to said body tissue;
providing at least one beneficial agent reservoir disposed adjacently to an electrically conductive area of at least one of said plurality of electrodes;
including a beneficial agent in said beneficial agent reservoir;
providing at least one semipermeable membrane in fluid communication with said at least one beneficial agent reservoir, said at least one semipermeable membrane configured to substantially inhibit passive diffusion of a beneficial agent therethough in the absence of an electrical current applied to said at least one semipermeable membrane and said beneficial agent;
implanting at least a portion of said at least one semipermeable membrane beneath a subject'"'"'s stratum corneum skin layer, wherein, responsive to said implanting, a circuit is completed between said plurality of electrodes, thus transmitting a voltage from said plurality of electrodes and said at least one semipermeable membrane to said body tissues, said voltage effecting transport of said beneficial agent through said at least one semipermeable membrane, said voltage facilitating transport of said beneficial agent through said body tissues; and
delivering said beneficial agent to the subject'"'"'s body tissues. - View Dependent Claims (30, 31, 32, 33, 34)
-
-
35. An intraocular delivery device for delivering a beneficial agent to a subject'"'"'s eye using liquid present on the surface of the subject'"'"'s conjunctiva to complete a circuit between two complementary electrodes configured within said intraocular drug delivery device, said intraocular drug delivery device comprising:
-
a membrane comprising a polymer, semipermeable to water, and further comprising first and second surfaces, said first surface being adapted to be placed on the subject'"'"'s conjunctiva to interact with any liquid present thereon, said second surface configured to contain a beneficial agent for delivery to the subject;
a first electrode in fluid communication with said membrane and said beneficial agent, said first electrode comprising a first electroactive material; and
a second electrode comprising a second electroactive material, said second electrode configured to be in fluid communication with the subject'"'"'s conjunctiva, but, except for conductive material connecting said first and second electrodes, electrically isolated from said first electrode, said first and second electroactive materials being selected, when configured together as a circuit, to form a battery;
wherein, when said intraocular drug delivery device is placed on the subject'"'"'s conjunctiva, any electrically conductive liquid present thereon completes an ionic circuit between said first and second electrodes, forming said battery which drives the beneficial agent through said membrane for delivery to the subject'"'"'s conjunctiva upon completing an electronic circuit. - View Dependent Claims (36, 37)
-
-
38. An improvement in an intraocular device for delivering beneficial agent to a subject'"'"'s eye of the type having a reservoir containing beneficial agent and a membrane for delivering the beneficial agent to the eye, the improvement comprising electronically delivering said beneficial agent to the subject'"'"'s eye.
Specification